Duration of Postpartum Magnesium Sulphate for the Prevention of Eclampsia: A Systematic Review and Meta-analysis
- PMID: 35271534
- DOI: 10.1097/AOG.0000000000004720
Duration of Postpartum Magnesium Sulphate for the Prevention of Eclampsia: A Systematic Review and Meta-analysis
Abstract
Objective: To estimate the optimal duration of postpartum magnesium sulphate to prevent eclampsia.
Data sources: MEDLINE, EMBASE, CINAHL, the Cochrane Database of Systematic Reviews, and ClinicalTrials.gov databases were searched from inception until January 2020 and limited to English-language human randomized controlled trials. Search strategy included the key works "eclampsia," "magnesium sulphate," and "postpartum."
Methods of study selection: Title, abstract, and full-text review was performed using Covidence data-management software. Of the 3,629 articles screened, 10 studies were included in the final review. Studies were included if they compared two different time points of magnesium sulphate postpartum in women with either preeclampsia or eclampsia.
Tabulation, integration and results: Two authors reviewed studies independently. RevMan software was used to calculate risk difference (RD) for categorical outcomes and mean difference for continuous outcomes. Shorter duration of magnesium sulphate (12 hours or less) was not associated with increased risk of eclampsia compared with 24-hour postpartum regimens (RD -0.01, 95% CI -0.02 to 0.01, I2 70%). Studies randomizing women with preeclampsia did not show increased risk of eclampsia with shorter regimens (RD 0, 95% CI -0.01 to 0.01, I2 0%), nor did trials randomizing those with eclampsia (RD -0.04, 95% CI -0.14 to 0.07, I2 87%). Secondary outcomes, including flushing, duration of Foley catheter insertion, time to ambulation, and duration of hospital stay, were all reduced with shorter-duration magnesium sulphate.
Conclusion: This systematic review and meta-analysis suggests that a shorter duration of postpartum magnesium sulphate does not increase the risk for eclamptic seizure; however, data remain underpowered to render firm conclusions.
Systematic review registration: PROSPERO, CRD42020182432.
Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Financial Disclosure The authors did not report any potential conflicts of interest.
Similar articles
-
Duration of postpartum magnesium sulfate for seizure prophylaxis in women with preeclampsia: a systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2022 Dec;35(25):7188-7193. doi: 10.1080/14767058.2021.1946505. Epub 2021 Jun 30. J Matern Fetal Neonatal Med. 2022. PMID: 34187284
-
Is there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study.BJOG. 2018 Sep;125(10):1304-1311. doi: 10.1111/1471-0528.15320. Epub 2018 Jul 11. BJOG. 2018. PMID: 29878650 Clinical Trial.
-
Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.J Obstet Gynaecol Can. 2014 Feb;36(2):154-163. doi: 10.1016/S1701-2163(15)30662-9. J Obstet Gynaecol Can. 2014. PMID: 24518915 Review.
-
Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.Cochrane Database Syst Rev. 2010 Aug 4;2010(8):CD007388. doi: 10.1002/14651858.CD007388.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2023 Oct 10;10:CD007388. doi: 10.1002/14651858.CD007388.pub3. PMID: 20687086 Free PMC article. Updated. Review.
-
Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.Cochrane Database Syst Rev. 2003;(2):CD000025. doi: 10.1002/14651858.CD000025. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2010 Nov 10;(11):CD000025. doi: 10.1002/14651858.CD000025.pub2. PMID: 12804383 Updated. Review.
Cited by
-
Efficacy of Magnesium Sulfate and Labetalol in the Treatment of Pregnancy-Induced Hypertension and Its Effect on Anxiety and Depression: A Retrospective Cohort Study.Alpha Psychiatry. 2024 Mar 1;25(2):243-248. doi: 10.5152/alphapsychiatry.2024.231342. eCollection 2024 Mar. Alpha Psychiatry. 2024. PMID: 38798818 Free PMC article.
-
Association Between Recurrent Preeclampsia and Attendance at the Blood Pressure Monitoring Appointment After Birth.J Obstet Gynecol Neonatal Nurs. 2024 Mar;53(2):132-139. doi: 10.1016/j.jogn.2023.11.002. Epub 2023 Nov 22. J Obstet Gynecol Neonatal Nurs. 2024. PMID: 38006903
-
Maternal and neonatal outcomes following magnesium sulfate in the setting of chorioamnionitis: a meta-analysis.Arch Gynecol Obstet. 2024 Mar;309(3):917-927. doi: 10.1007/s00404-023-07221-3. Epub 2023 Sep 28. Arch Gynecol Obstet. 2024. PMID: 37768342 Free PMC article. Review.
References
-
- Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014;36:416–41. doi: 10.1016/s1701-2163(15)30588-0 - DOI
-
- National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133]. Accessed October 1, 2021. www.nice.org.uk/guidance/ng133
-
- Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists. Obstet Gynecol 2020;135:e237–60. doi: 10.1097/AOG.0000000000003891 - DOI
-
- Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 2004;190:1520–6. doi: 10.1016/j.ajog.2003.12.057 - DOI
-
- Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with preeclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:1877–90. doi: 10.1016/s0140-6736(02)08778-0 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous